Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Vigna

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 2, 2023
Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum periodAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Hematology Reports|July 25, 2023
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic PurpuraAntonella Bruzzese, Ernesto Vigna, Dario Terzi, et al.
Nutrients|May 13, 2026
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational OpportunitiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|June 23, 2026
Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-MakingMamdouh Skafi, Santino Caserta, Enrica Antonia Martino, et al.
Expert Opinion on Investigational Drugs|January 11, 2011
Lenalidomide in the treatment of chronic lymphocytic leukemiaMassimo Gentile, Anna Grazia Recchia, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|December 7, 2010
Janus kinase 2 inhibitors in myeloproliferative disordersEugenio Lucia, Anna Grazia Recchia, Massimo Gentile, et al.
European Journal of Haematology|March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocolFortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
European Journal of Haematology|May 14, 2026
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted TherapyEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|March 9, 2011
Epigenetic regulation in myelodysplastic syndromes: implications for therapyErnesto Vigna, Anna Grazia Recchia, Antonio Madeo, et al.
Blood|October 15, 2011
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemiaFortunato Morabito, Rosaria De Filippi, Luca Laurenti, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 2, 2023
Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum periodAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Hematology Reports|July 25, 2023
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic PurpuraAntonella Bruzzese, Ernesto Vigna, Dario Terzi, et al.
Nutrients|May 13, 2026
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational OpportunitiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|June 23, 2026
Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-MakingMamdouh Skafi, Santino Caserta, Enrica Antonia Martino, et al.
Expert Opinion on Investigational Drugs|January 11, 2011
Lenalidomide in the treatment of chronic lymphocytic leukemiaMassimo Gentile, Anna Grazia Recchia, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|December 7, 2010
Janus kinase 2 inhibitors in myeloproliferative disordersEugenio Lucia, Anna Grazia Recchia, Massimo Gentile, et al.
European Journal of Haematology|March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocolFortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
European Journal of Haematology|May 14, 2026
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted TherapyEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|March 9, 2011
Epigenetic regulation in myelodysplastic syndromes: implications for therapyErnesto Vigna, Anna Grazia Recchia, Antonio Madeo, et al.
Blood|October 15, 2011
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemiaFortunato Morabito, Rosaria De Filippi, Luca Laurenti, et al.
Pageof 12